Cargando…
PD-L1 Testing and Squamous Cell Carcinoma of the Head and Neck: A Multicenter Study on the Diagnostic Reproducibility of Different Protocols
SIMPLE SUMMARY: The introduction of therapies with immune checkpoint inhibitors targeting the programmed cell death protein 1 and its ligand (PD-L1) axis in head and neck squamous cell carcinoma prompted the need of reliable bio-selectors to stratify patients that would benefit from these treatments...
Autores principales: | Crosta, Simona, Boldorini, Renzo, Bono, Francesca, Brambilla, Virginia, Dainese, Emanuele, Fusco, Nicola, Gianatti, Andrea, L’Imperio, Vincenzo, Morbini, Patrizia, Pagni, Fabio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7830149/ https://www.ncbi.nlm.nih.gov/pubmed/33466794 http://dx.doi.org/10.3390/cancers13020292 |
Ejemplares similares
-
Effect of Radio-Chemotherapy on PD-L1 Immunohistochemical Expression in Head and Neck Squamous Cell Carcinoma
por: Girolami, Ilaria, et al.
Publicado: (2023) -
The Reproducibility of the Immunohistochemical PD-L1 Testing in Non-Small-Cell Lung Cancer: A Multicentric Italian Experience
por: Vigliar, Elena, et al.
Publicado: (2019) -
Digital pathology for the routine diagnosis of renal diseases: a standard model
por: L’Imperio, Vincenzo, et al.
Publicado: (2020) -
Ex vivo thyroid fine needle aspirations as an alternative for MALDI-MSI proteomic investigation: intra-patient comparison
por: Piga, Isabella, et al.
Publicado: (2020) -
Renal involvement in eosinophilic granulomatosis with polyangiitis
por: Reggiani, Francesco, et al.
Publicado: (2023)